Full List Of Stories
Motif Bio reaches settlement with former clinical research organisation
Motif Bio announced on Monday that its subsidiary Motif BioSciences has reached an agreement with its former clinical research organisation to settle all obligations without further payment.
Open Orphan inks preferred partner deal with Ipsen Group
Europe-focussed rare and orphan drug consulting services platform Open Orphan announced the signing of a preferred partner agreement with Ipsen Group on Monday.
InfraStrata raises £6m for acquisition of Harland & Wolff
Strategic infrastructure project investor InfraStrata announced a proposed placing of new ordinary shares by way of an accelerated bookbuild on Monday, to raise a minimum of £6m.
Bacanora Lithium pleased with progress at Sonora Project
Bacanora Lithium updated the market on its activities at the Sonora Lithium Project in Mexico on Monday, following the recent completion of the strategic investment by global lithium company Ganfeng Lithium.
IndigoVision buys Portuguese software firm Agora
IndigoVision announced the acquisition of Agorasys for a consideration of up to €3. 0m (£2. 57m) on Monday, of which €2. 3m would be payable in cash at completion to clear Agora's existing financial indebtedness.
AFC Energy surges on recent testing of 'AlkaMem' technology
Hydrogen power generation technology provider AFC Energy updated the market on its proprietary ‘AlkaMem’ anionic exchange membrane development programme on Monday, as used in its high-current density alkaline fuel cell, ‘HydroX-Cell(S)’.
Asia report: Most markets fall amid boiling political tensions
Most markets in Asia finished in the red on Monday, with Australasian bourses being the exception, as political and trade tensions remained extraordinarily tight in the region.
Yew Grove sells non-core asset for EUR 1.1m
Ireland-focussed commercial property investor Yew Grove REIT has reached an agreement to sell one of its non-core industrial properties on Heather Road in Sandyford, for €1. 1m (£0. 94m) to an international investor.
Roche releases positive data from latest 'Gazyva' trial
Roche announced data from the phase 2 ‘NOBILITY’ study investigating the safety and efficacy of ‘Gazyva’, or obinutuzumab, for adults with proliferative lupus nephritis on Monday.
Paul Fletcher joining Vast Resources board as finance director
Mining company Vast Resources announced the appointment of Paul Fletcher as its finance director on Monday, with immediate effect.
Serabi Gold turns in solid third quarter performance
Brazil-focussed gold mining and development company Serabi Gold reported EBITDA of $4. 6m (£3. 59m) in its third quarter results on Monday, swinging from the small loss it made at the same time last year.
Falanx Group flags 20pc revenue rise in first half
Cybersecurity and intelligence services provider Falanx Group announced on Monday that its interim results for the six months ended 30 September will be released on 3 December.
Argo Blockchain brings 500 new mining machines online
Enterprise-scale cryptocurrency mining company Argo Blockchain announced on Monday that 500 new ‘Bitmain S17 Antminer’ machines had been brought onstream in the last week, increasing the total number of machines in production to 7,000.
AstraZeneca upbeat on latest roxadustat trial data
AstraZeneca, along with its partner FibroGen, presented pooled efficacy and cardiovascular safety analyses from the pivotal phase 3 programme assessing ‘roxadustat’ on Monday, for the treatment of patients with anaemia from chronic kidney disease (CKD).
Informa maintains guidance amid some market struggles
Exhibitions, events, information services and education provider Informa updated the market on the 10 month period ending 31 October on Monday, reporting continued growth in revenue, adjusted profit, earnings and cash flow, adding that it was on track to achieve its forecast full-year performance.